Vaginal cleansing before cesarean delivery to reduce postoperative infectious morbidity: a randomized, controlled trial

Objective The objective of the study was to determine whether vaginal preparation with povidone iodine before cesarean delivery decreased the risk of postoperative maternal morbidities. Study Design The design of the study was a randomized, controlled trial in women undergoing cesarean delivery with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of obstetrics and gynecology 2010-03, Vol.202 (3), p.310.e1-310.e6
Hauptverfasser: Haas, David M., MD, MS, Pazouki, Fatemeh, MD, Smith, Ronda R, Fry, Amy M., MD, Podzielinski, Iwona, MD, Al-Darei, Sarah M., MD, Golichowski, Alan M., MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective The objective of the study was to determine whether vaginal preparation with povidone iodine before cesarean delivery decreased the risk of postoperative maternal morbidities. Study Design The design of the study was a randomized, controlled trial in women undergoing cesarean delivery with subjects assigned to have a preoperative vaginal cleansing with povidone iodine or to a standard care group (no vaginal wash). The primary outcome was a composite of postoperative fever, endometritis, sepsis, readmission, wound infection, or complication. Results There were 155 vaginal cleansing subjects and 145 control subjects. Overall, 9.0% developed the composite outcome, with fewer women in the cleansing group (6.5%) compared with the control group (11.7%), although the difference was not statistically significant (relative risk, 0.55; 95% confidence interval, 0.26–1.11; P = .11). Length of surgery, being in labor, and having a dilated cervix were all associated with the composite morbidity outcome. Conclusion Vaginal cleansing with povidone iodine before cesarean delivery may decrease postoperative morbidities, although the reduction is not statistically significant.
ISSN:0002-9378
1097-6868
DOI:10.1016/j.ajog.2010.01.005